Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katerina Kafantari"'
Autor:
Panagiotis Andreadis, Katerina Kafantari, Aleka Agapidou, Sofia Vakalopoulou, Efthymia Vlachaki
Publikováno v:
Balkan Medical Journal, Vol 35, Iss 1, Pp 112-115 (2018)
A 78-year-old male presented to the emergency department due to repeated episodes of syncope over the last 3 days. Physical examination during admission revealed pallour and extensive ecchymosis in his left hemithorax and left thigh. The rest of the
Externí odkaz:
https://doaj.org/article/1de68866a6554ec99d09133c743e444c
Autor:
Katerina Kafantari, Sofia Vakalopoulou, Efthymia Vlachaki, Aleka Agapidou, Panagiotis Andreadis
Publikováno v:
Balkan Medical Journal
Volume: 35, Issue: 1 112-115
Balkan Medical Journal, Vol 35, Iss 1, Pp 112-115 (2018)
Volume: 35, Issue: 1 112-115
Balkan Medical Journal, Vol 35, Iss 1, Pp 112-115 (2018)
Background Acquired coagulation factor inhibitors are antibodies that either inhibit activity or increase the clearance of a clotting factor and lead to an increased risk of bleeding. Most of the time, the disorder is attributed to factor VIII inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::833b9d7c081f5bc3237c91e412734d68
http://europepmc.org/articles/PMC5820439
http://europepmc.org/articles/PMC5820439
Autor:
Eleni Gavriilaki, Katerina Kafantari, Achilles Anagnostopoulos, Eleni Chasapopoulou, Despoina Adamidou, Dimitris A. Tsitsikas, Apostolos Tsapas, Efthymia Vlachaki
Delayed hemolytic transfusion reaction (DHTR) is a life-threatening complication in patients with sickle cell disease, characterized by difficulties in diagnosis and management. Certain reports have suggested successful salvage treatment with the ter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3139e9ef1c1815880e49d8c0605069f
Autor:
Fotini Adamidou, Paraskevi Komzia, Thomas Georgiou, Anastasios Vagionas, Marina Kita, Katerina Kafantari
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c11239e1350179f442d28d776b5b1db1
https://doi.org/10.1530/endoabs.56.gp192
https://doi.org/10.1530/endoabs.56.gp192
Autor:
Eleni Kapsali, Katerina Kafantari, Sofia Vakalopoulou, Efthymia Vlachaki, Evaggelia Vetsiou, Aggeliki Kotsiafti, Maria Mainou, Chrysoula Apostolou, Philippos Klonizakis
Publikováno v:
Hemoglobin. 41:223-224
The use of rivaroxaban in patients with hemoglobinopathies and thrombotic events has not been studied extensively. Here we present eight cases of such patients, five receiving rivaroxaban for stroke and systemic embolism prevention due to non-valvula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5e57190b0a1cada407ab20180d22f20
https://doi.org/10.1080/03630269.2017.1374969
https://doi.org/10.1080/03630269.2017.1374969